iCo Therapeutics has been selected as a finalist in Canada’s Top 10 Life Sciences Companies Competition for 2005/2006. In being named one of Canada’s Top 10, the Council recognizes iCo Therapeutics’ future investment potential and provides iCo the opportunity to present to the North American investment community at the prestigious BioNorth 2005, a premier conference for life sciences companies.
